These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16191092)

  • 1. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.
    Iga D; Tomimatsu M; Endo H; Ohkawa S; Yamada O
    Eur J Haematol; 2005 Nov; 75(5):417-23. PubMed ID: 16191092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia in patients with HCV-positive chronic hepatitis: efficacy of leucocyte interferon-alpha treatment.
    Benci A; Caremani M; Tacconi D
    Int J Clin Pract; 2003; 57(1):17-9. PubMed ID: 12587936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus-related thrombocytopenia: clinical and laboratory characteristics compared with chronic immune thrombocytopenic purpura.
    Rajan SK; Espina BM; Liebman HA
    Br J Haematol; 2005 Jun; 129(6):818-24. PubMed ID: 15953010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the influencing factors of thrombocytopenia in viral hepatitis].
    Jiang XH; Xie YT; Tan DM
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):734-6. PubMed ID: 15619340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune thrombocytopenia associated with interferon therapy of hepatitis C with the anti-CD20 monoclonal antibody, rituximab.
    Weitz IC
    Am J Hematol; 2005 Feb; 78(2):138-41. PubMed ID: 15682410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical analysis of thrombocytopenia in chronic dialysis patients].
    Iwamoto Y; Ando M; Tsuchiya K; Nihei H
    Nihon Jinzo Gakkai Shi; 1999 Oct; 41(7):712-8. PubMed ID: 10572397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in viral kinetics between genotypes 1 and 2 of hepatitis C virus after single administration of standard interferon-alpha.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Atsumi H; Takagi M; Nakano S; Arakawa T; Fujimori M
    J Med Virol; 2009 Aug; 81(8):1354-62. PubMed ID: 19551828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-associated thrombocytopenia: a controlled prospective, virological study.
    de Almeida AJ; Campos-de-Magalhães M; de Melo Marçal OP; Brandão-Mello CE; Okawa MY; de Oliveira RV; do Espírito-Santo MP; Yoshida CF; Lampe E
    Ann Hematol; 2004 Jul; 83(7):434-40. PubMed ID: 14963696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet associated immunoglobulin in the pathogenesis of thrombocytopenia in patients with chronic liver disease].
    Jiang XH; Xie YT; Tan DM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):566-8. PubMed ID: 16137048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombocytopenia in chronic hepatitis C.
    Olariu M; Olariu C; Olteanu D
    J Gastrointestin Liver Dis; 2010 Dec; 19(4):381-5. PubMed ID: 21188328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin or interleukin-6 has no effect on thrombocytopenia of cirrhosis.
    Ozer B; Serin E; Sezgin N; Cosar A; Güclü M; Gur G; Yilmaz U; Boyacioglu S
    Hepatogastroenterology; 2007 Jun; 54(76):1187-91. PubMed ID: 17629067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia in patients with chronic hepatitis C: a possible role of HCV on platelet progenitor cell maturation.
    El Barbary MA; Saad AE; Attia FM; Mandour MI; Haidara MA; Dallak MM; Isenovic ER
    Angiology; 2010 Apr; 61(3):304-13. PubMed ID: 19689996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
    Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
    Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A multi-center clinical trial of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in patients with solid tumor].
    Bai CM; Xu GX; Zhao YQ; Han SM; Shan YD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):437-41. PubMed ID: 15379272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-four hour kinetics of hepatitis C virus and antiviral effect of alpha-interferon.
    Boulestin A; Kamar N; Sandres-Sauné K; Legrand-Abravanel F; Alric L; Vinel JP; Rostaing L; Izopet J
    J Med Virol; 2006 Mar; 78(3):365-71. PubMed ID: 16419107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C.
    Xu DZ; Xie Y; Li ZQ
    Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):550-3. PubMed ID: 16286260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombocytopenia in HCV infection. Natural interferon as an alternative therapy].
    Krzowska-Firych J; Modrzewska R; Kiciak SG
    Przegl Epidemiol; 2007; 61(4):771-6. PubMed ID: 18572510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.